elevet+ ampiclox® dry cow intramammary antibiotic
avet health limited - ampicillin trihydrate; cloxacillin as the benzathine salt - misc. intra mammary - ampicillin trihydrate antibiotic active 250.0 mg/sg; cloxacillin as the benzathine salt antibiotic active 500.0 mg/sg - antibiotic & related - cow-not lactating-preg. not w/i 1mth cal | dairy cattle dry | dairy cattle lactating | bovine | cow | cow pregnant not within 1 - antibiotic - anti-infective | abrasions | abscesses | airsacculitis | antiseptic | avian mycoplasmas | blackhead | body odours | bowed tendons | broad spectrum | burns | coccidiosis | coliform complex | conjunctivitis | cowpox | cracks | crusts | dandruff | dermatological disorders | dermatosis | dry skin | dysentery | eczema | endometritis | enteric diseases | enzootic pneumonia | feed efficiency | fungal infections | girth galls | infections | inflammed pads | itching | keratolytic | lacerations | mastitis | mycoplasmas | odours | open wounds | otitis | pruritis | queensland itch | respiratory disease | saddle rash | salmonellosis | scabs | scaly skin | sheath rot | skin irritations | sores | swine dysentery | teat cracking | teat infections | topical infections | udder sores | weight gain | wire cuts | wounds
mp-clox suspension, oral ampicillin trihydrate 125 and cloxacillin sodium 125
zenufa laboratories (t) limited, tanzania - ampicillin trihydrate , cloxacillin sodium - suspension, oral - ampicillin trihydrate 125 and cloxacillin sodium 125
bovaclox dc la dry cow intramammary suspension
norbrook laboratories australia pty limited - ampicillin trihydrate; cloxacillin as the benzathine salt - misc. intra mammary - ampicillin trihydrate antibiotic active 300.0 mg/sg; cloxacillin as the benzathine salt antibiotic active 600.0 mg/sg - antibiotic & related - dairy cattle | bovine | breeders | calves | dairy cow | growers | lactating cow | milking cow - corynebacterium pyogenes | mastitis | staphylococcus spp. | streptococcus agalactiae | staphylococcosis | subclinical mastitis
bovaclox dry cow
schering-plough animal health limited - ampicillin trihydrate; cloxacillin benzathine - ampicillin trihydrate 55.5 g/litre; cloxacillin benzathine 111.1 g/litre - antibiotic
cloxamp dc 500
norbrook nz limited - ampicillin trihydrate; cloxacillin benzathine - ampicillin trihydrate 55.5 g/kg; cloxacillin benzathine 111.1 g/kg - antibiotic
dryclox dc
elanco new zealand - ampicillin trihydrate; cloxacillin benzathine - ampicillin trihydrate 55.5 g/kg; cloxacillin benzathine 111.1 g/kg - antibiotic
fraclox capsules 500mg capsule, hard
harleys limited 63 westland's road. - ampicillin trihydrate bp, cloxacillin sodium bp - capsule, hard - ampicillin 250 + cloxacillin 250 capsules - ampicillin
ampicillin and sulbactam- ampicillin sodium and sulbactam sodium injection, powder, for solution
sandoz inc - ampicillin sodium (unii: jfn36l5s8k) (ampicillin - unii:7c782967rd), sulbactam sodium (unii: dkq4t82ye6) (sulbactam - unii:s4tf6i2330) - ampicillin 1 g - ampicillin and sulbactam for injection is indicated for the treatment of infections due to susceptible strains of the designated microorganisms in the conditions listed below. skin and skin structure infections caused by beta-lactamase producing strains of staphylococcus aureus, escherichia coli*, klebsiella spp.* (including k. pneumoniae* ), proteus mirabilis*, bacteroides fragilis*, enterobacter spp. *, and acinetobacter calcoaceticus*. note: for information on use in pediatric patients (see precautions - pediatric use and clinical studies sections). intra-abdominal infections caused by beta-lactamase producing strains of escherichia coli, klebsiella spp. (including k. pneumoniae*) , bacteroides spp. (including b. fragilis ), and enterobacter spp.* gynecological infections caused by beta-lactamase producing strains of escherichia coli*, and bacteroides spp.* (including b. fragilis* ). *efficacy for this organism in this organ system was studied in fewer than 10 infections. while ampicillin and s
ampicillin- ampicillin sodium injection, powder, for solution
fresenius kabi usa, llc - ampicillin sodium (unii: jfn36l5s8k) (ampicillin - unii:7c782967rd) - ampicillin 250 mg - ampicillin for injection is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the following conditions: respiratory tract infections caused by streptococcus pneumoniae . staphylococcus aureus (penicillinase and nonpenicillinase-producing), h. influenzae, and group a beta-hemolytic streptococci . bacterial meningitis caused by e. coli, group b streptococci , and other gram-negative bacteria (listeria monocytogenes, n. meningitidis ). the addition of an aminoglycoside with ampicillin may increase its effectiveness against gram-negative bacteria. septicemia and endocarditis caused by susceptible gram-positive organisms including streptococcus spp., penicillin g-susceptible staphylococci , and enterococci . gram-negative sepsis caused by e. coli, proteus mirabilis and salmonella spp. responds to ampicillin. endocarditis due to enterococcal strains usually respond to intravenous therapy. the addition of an aminoglycoside may enhance the effectiveness of
ampicillin- ampicillin sodium injection, powder, for solution
sandoz inc - ampicillin sodium (unii: jfn36l5s8k) (ampicillin - unii:7c782967rd) - ampicillin 250 mg - ampicillin for injection is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the following conditions: respiratory tract infections caused by streptococcus pneumoniae . staphylococcus aureus (penicillinase and nonpenicillinase-producing), h. influenzae, and group a beta-hemolytic streptococci. bacterial meningitis caused by e. coli, group b streptococci , and other gram-negative bacteria (listeria monocytogenes, n. meningitidis ). the addition of an aminoglycoside with ampicillin may increase its effectiveness against gram-negative bacteria. septicemia and endocarditis caused by susceptible gram-positive organisms including streptococcus spp., penicillin g-susceptible staphylococci , and enterococci . gram-negative sepsis caused by e. coli, proteus mirabilis and salmonella spp. responds to ampicillin. endocarditis due to enterococcal strains usually respond to intravenous therapy. the addition of an aminoglycoside may enhance the effectiveness of a